Skip to main content
. 2023 Feb 18;5(5):100702. doi: 10.1016/j.jhepr.2023.100702

Fig. 5.

Fig. 5

Forest plot.

(A) Forest plot, RRs and corresponding 95% CIs for the association between sorafenib and the risk of AEs of grade 3 or higher, considering sorafenib as reference. (B) Forest plot, RR and corresponding 96% Cs for the association between sorafenib and the risk of AEs of any grade, considering sorafenib as reference. AE, adverse event; RR, relative risk.